- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00604799
VALOR: The Talent Thoracic Stent Graft System Clinical Study (VALOR)
October 27, 2021 updated by: Medtronic Cardiovascular
Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms
A Descending Thoracic Aneurysm is a bulge in the aorta.
The aorta is a large blood vessel that carries blood away from your heart to organs in the rest of your body.
Your aneurysm is caused by a weakening in the artery wall.
If left untreated, this bulge may continue to grow larger and may ultimately rupture (break open) or extend in size to seriously affect other major arteries in the area.
In this Research Study a device will be placed inside your aorta to block the weakened part of the artery wall from the circulatory system.
Information will be collected on the performance for the device for 5 years.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
379
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Talent Captivia Inclusion Criteria
- Patient is at least 18 years of age.
- Patient is a surgical or non-surgical candidate
Patient has a:
- Fusiform focal TAA AND / OR
- Focal saccular TAA or penetrating atherosclerotic ulcer.
Subject's anatomy must meet all of the following anatomical criteria:
- iliac/femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories
- non-aneurysmal aortic diameter in the range of 18-42mm; and
- non-aneurysmal aortic proximal and distal neck lengths =/>20mm
- Thoracic aortic lesion is confirmed, at a minimum, by diagnostic contrast enhanced computerized tomography (CTA) with optional 3-D reconstruction, and/or contrast enhanced Magnetic Resonance Angiogram (MRA) obtained within the previous three (3) months prior to the implant procedure.
- Subject or subject's legal representative understands and has signed an Informed Consent approved by the Sponsor and by the IRB for this study.
- Patient must be able and willing to undergo follow-up imaging and examinations postoperatively up to 6 months.
Talent Captivia Exclusion Criteria
- Planned placement of the COVERED (top edge of fabric) portion of the stent graft requires implant to occur in zones 0 or 1
- Pregnant female
- Patient has a connective tissue disease (e.g Marfan's syndrome, medial degeneration).
- Patient has a mycotic aneurysm or is suspected of having systemic infection.
- Patient has a history of bleeding diathesis, coagulopathy, or refuses blood transfusions.
- Patient is currently participating in an investigational drug or device clinical trial that would interfere with the Talent Captivia protocol endpoints or follow-up.
- The patient has known allergy or intolerance to the device components.
- The patient has a known hypersensitivity or contraindication to anticoagulants or contrast media, which is not amenable to pre-treatment.
- The patient has another medical condition, which may cause them to be non-compliant with the protocol, confound the data interpretation, or limited life expectancy of less than 6 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Test (Enrollment Completed)
Patients diagnosed with a TAA of degenerative etiology that are considered candidates for open surgical repair whom are low to moderate risk (0, 1, & 2) per the modified SVS/AAVS criteria who meet inclusion/exclusion criteria.
The aneurysm must be at least 20 mm distal to the left common carotid artery & 20 mm proximal to the origin of the celiac artery.
|
TEVAR
|
Other: Registry (Enrollment Completed)
Surgical candidates of low to moderate risk (SVS 0, 1, 2) that meet the Registry Inclusion/Exclusion criteria.
|
TEVAR
|
Other: High Risk (Enrollment Completed)
Patients that meet one or more of the following:
|
TEVAR
|
Other: Talent Captivia (Recruiting)
Patients diagnosed with a TAA of degenerative etiology that are considered candidates for open surgical repair who meet inclusion/exclusion criteria.
|
TEVAR
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Primary Efficacy Endpoint: proportion of patients in the Test Group who have successful aneurysm treatment at the 12-month follow-up visit.
Time Frame: 12 months
|
12 months
|
Primary Safety Endpoint: rate of "all cause" mortality of TAA repair with the Talent Thoracic Stent Graft against the literature control for open surgical repair within 1 year of follow-up.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christopher Kwolek, MD, Massachusetts General Hospital
- Principal Investigator: Mark Kaye, MD, Physician's Regional Medical Center
- Principal Investigator: Phillip Allmendinger, MD, Hartford Hospital
- Principal Investigator: Mark Bates, MD, CAMC Health System
- Principal Investigator: Daniel Benckart, MD, West Penn Allegheny Health System
- Principal Investigator: Paul Bove, MD, William Beaumont Hospitals
- Principal Investigator: Thomas Bower, MD, Mayo Clinic
- Principal Investigator: Alfio Carroccio, MD, Mt. Sinai School of Medicine
- Principal Investigator: Neal Cayne, MD, NYU Vascular Associates
- Principal Investigator: Frank Criado, MD, Union Memorial Hospital
- Principal Investigator: Alan Matsumoto, MD, University of Virginia
- Principal Investigator: Mark Eskandari, MD, Northwestern Memorial Hospital
- Principal Investigator: James McKinsey, MD, New York Presbyterian (Columbia & Cornell)
- Principal Investigator: H. Edward Garrett, MD, Baptist Memorial Hospital
- Principal Investigator: Marc Glickman, MD, Sentar Norfolk General
- Principal Investigator: Kim Hodgson, MD, Memorial Medical Center
- Principal Investigator: Matthew Jung, MD, Surgical Care Associates
- Principal Investigator: Barry Katzen, MD, Baptist Health South Florida
- Principal Investigator: Zvonimir Krajcer, MD, St. Luke's Episcopal Hospital-Houston
- Principal Investigator: Lowell Satler, MD, MedStar Health Research Institute
- Principal Investigator: Anthony Lee, MD, University of Florida
- Principal Investigator: Alan Lumsden, MD, Baylor College of Medicine
- Principal Investigator: Sean Lyden, MD, Cleveland Clinic Foundation-Ohio
- Principal Investigator: Richard McCann, MD, Duke University
- Principal Investigator: Manish Mehta, MD, Vascular Group, PLLC
- Principal Investigator: Mark Mewissen, MD, St. Luke's Vascular Center
- Principal Investigator: Takao Ohki, MD, Montefiore Medical Center
- Principal Investigator: Robert Rhee, MD, Shadyside Hospital-UPMC
- Principal Investigator: Timothy Roush, MD, Carolinas Medical Center
- Principal Investigator: Gregoria Sicard, MD, Washington University School of Medicine
- Principal Investigator: Cary Stowe, MD, AdventHealth
- Principal Investigator: Jim Swischuk, MD, Saint Francis Memorial Hospital
- Principal Investigator: Michael Tuchek, MD, Loyola University
- Principal Investigator: Rodney White, MD, Harbor UCLA
- Principal Investigator: David Williams, MD, University of Michigan
- Principal Investigator: Christopher Zarins, MD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2003
Primary Completion (Actual)
June 1, 2006
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
December 21, 2007
First Submitted That Met QC Criteria
January 28, 2008
First Posted (Estimate)
January 30, 2008
Study Record Updates
Last Update Posted (Actual)
November 2, 2021
Last Update Submitted That Met QC Criteria
October 27, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Investigational Plan #031
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracic Aortic Aneurysms
-
Medtronic CardiovascularCompletedThoracic Aortic AneurysmsUnited States, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenRecruitingThoracic Aortic AneurysmsBelgium
-
Medtronic CardiovascularMedtronicTerminatedThoracic Aortic AneurysmsUnited States
-
Bolton MedicalCompletedThoracic Aortic Aneurysms | and Penetrating Atherosclerotic UlcersUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedAbdominal Aortic AneurysmsFrance
-
IRCCS San RaffaeleCompletedAortic Aneurysm, Thoracoabdominal | Para-renal Aortic AneurysmsItaly
-
Lifetech Scientific (Shenzhen) Co., Ltd.Unknown
-
Scientific Institute San RaffaeleCompleted
-
Sanford HealthActive, not recruitingThoracoabdominal AneurysmsUnited States
-
University of South FloridaMedtronic; Sanford HealthActive, not recruiting
Clinical Trials on Talent Thoracic Stent Graft
-
Medtronic CardiovascularMedtronicTerminatedThoracic Aortic AneurysmsUnited States
-
Stanford UniversityCompleted
-
Medtronic CardiovascularThe Cleveland ClinicTerminated
-
Medtronic CardiovascularCompletedAortic Aneurysm, AbdominalUnited States
-
Medtronic CardiovascularNo longer availableAbdominal Aortic AneurysmsUnited States
-
Center for Vascular Awareness, Albany, New YorkUnknownAbdominal Aortic AneurysmUnited States
-
Arizona Heart InstituteUnknownAbdominal Aortic AneurysmUnited States
-
TriVascular, Inc.Completed
-
Bolton MedicalApproved for marketingThoracic Aortic Aneurysm | Penetrating UlcersUnited States